Effects of a novel ACE inhibitor, 3-(3-thienyl)-l-alanyl-ornithyl-proline, on endothelial vasodilation and hepatotoxicity in l-NAME-induced hypertensive rats

References

• SafarMELevyBIStruijker-BoudierHCurrent perspectives on arterial stiffness and pulse pressure in hypertension and cardiovascular diseasesCirculation20031072864286912796414
   PubMed Web of Science ®Google Scholar
• KoboriHNangakuMNavarLGNishiyamaAThe intrarenal renin-angiotensin system: from physiology to the pathobiology of hypertension and kidney diseasePharmacol Rev200759325128717878513
   PubMed Web of Science ®Google Scholar
• BaderMGantenDUpdate on tissue renin–angiotensin systemsJ Mol Med20088661562118414822
   PubMed Web of Science ®Google Scholar
• ErdösEGTanFSkidgelRAAngiotensin I-converting enzyme inhibitors are allosteric enhancers of kinin B1 and B2 receptor functionHypertension201055221422020065150
   PubMed Web of Science ®Google Scholar
• DabiréHBarthélémyIBlanchard-GuttonNVascular endothelial dysfunction in Duchenne muscular dystrophy is restored by bradykinin through upregulation of eNOS and nNOSBasic Res Cardiol2012107119
   Web of Science ®Google Scholar
• SiguschHHCampbellSEWeberKTAngiotensin II-induced myocardial fibrosis in rats: role of nitric oxide, prostaglandins and bradykininCardiovasc Res19963145465548689646
   PubMed Web of Science ®Google Scholar
• HanifKSnehlataPavarMCEffect of 3-thienylalanine-ornithine-proline, new sulfur-containing angiotensin-converting enzyme inhibitor on blood pressure and oxidative stress in spontaneously hypertensive ratsJ Cardiovasc Pharmacol200953214515019188834
   PubMed Web of Science ®Google Scholar
• PavarMCHanifKAzamALataSQadar PashaMAPashaSStructure-activity relationship study between Ornithyl-Proline and Lysyl-Proline based tripeptidomimics as angiotensin-converting enzyme inhibitorsBioorg Med Chem Lett200616821122117
   Web of Science ®Google Scholar
• LüscherTFVanhouttePMThe Endothelium: Modulator of Cardiovascular FunctionsBoca Raton, FLCRC Press19911228
   Google Scholar
• KunešJHojnáSKadlecováMAltered balance of vasoactive systems in experimental hypertension: the role of relative NO deficiencyPhysiol Res2004531S23S3415119933
   PubMedGoogle Scholar
• MoncadaSNitric oxide gas: mediator, modulator, and pathophysiologic entityJ Lab Clin Med19921201871911500817
   PubMed Web of Science ®Google Scholar
• NavaEFarreAMorenoCAlterations to the nitric oxide pathway in the spontaneously hypertensive ratJ Hypertens1998166096159797172
   PubMedGoogle Scholar
• MacarthurHWestfallTCWilkenGHOxidative stress attenuates NO-induced modulation of sympathetic neurotransmission in the mesenteric arterial bed of spontaneously hypertensive ratsAm J Physiol Heart Circ Physiol2008294H183H18917965279
   PubMed Web of Science ®Google Scholar
• TörökJParticipation of nitric oxide in different models of experimental hypertensionPhysiol Res20085781382519154086
   PubMed Web of Science ®Google Scholar
• RomeroJCReckelhoffJFRole of angiotensin and oxidative stress in essential hypertensionHypertension19993494394910523389
   PubMed Web of Science ®Google Scholar
• BernátováIPecháňováOŠimkoFEffect of captopril in L-NAME-induced hypertension on the rat myocardium, aorta, brain and kidneyExp Physiol1999841095110510564706
   PubMed Web of Science ®Google Scholar
• GreenLCWagnerDAGlagowskiJAnalysis of nitrate, nitrite and [15N] nitrate in biological fluidsAnal Biochem19821261311387181105
   PubMed Web of Science ®Google Scholar
• BalaMQadar PashaMABhardwajDKNovel peptidomimics as angiotensin converting enzyme inhibitors: a combinatorial approachBioorg Med Chem2002103685369112213484
   PubMed Web of Science ®Google Scholar
• WrightJRColbyHDMilesPRCytosolic factors that affect microsomal lipid peroxidation in lung and liverArch Biochem Biophys19812062963047224639
   PubMed Web of Science ®Google Scholar
• VatsIDSnehlataNathMPashaMAPashaSEffect of chronic intra-peritoneally administered chimeric peptide of met-enkephalin and FMRFa-[D-Ala2] YFa on antinociception and opioid receptor regulationEur J Pain2009143295.e1295.e919560378
   PubMed Web of Science ®Google Scholar
• FörstermannUKleinertHNitric oxide synthase: expression and expressional control of the three isoformsNaunyn Schmiedebergs Arch Pharmacol199535243513648532063
   PubMed Web of Science ®Google Scholar
• MarínJRodríguez-MartínezMARole of vascular nitric oxide in physiological and pathological conditionsPharmacol Ther19977521111349428001
   PubMed Web of Science ®Google Scholar
• MaxwellAJSchaubleEBernsteinDCookeJPLimb blood flow during exercise is dependent on nitric oxideCirculation19989843693749711943
   PubMed Web of Science ®Google Scholar
• PecháňováOBernátováIPelouchVSimkoFProtein remodelling of the heart in NO-deficient hypertension: the effect of captoprilJ Mol Cell Cardiol199729336533749441842
   PubMed Web of Science ®Google Scholar
• LincolnJBurnstockGNeural-endothelial interactions in control of local blood flowWarrenJThe Endothelium: An Introduction to Current ResearchNew York, NYWiley-Liss19902131
   Google Scholar
• TörökJGerováMVascular responses after long-term inhibition of nitric oxide synthesis in newborn dogsPhysiol Res1996453233289085357
   PubMed Web of Science ®Google Scholar
• HolécyováATörökJBernátováIPechánováORestriction of nitric oxide rather than elevated blood pressure is responsible for alterations of vascular responses in nitric oxide-deficient hypertensionPhysiol Res1996453173219085356
   PubMed Web of Science ®Google Scholar
• HsiehNKWangJYLiuJCWangSDChenHINitric oxide inhibition accelerates hypertension and induces perivascular inflammation in ratsClin Exp Pharmacol Physiol20043121221815053816
   PubMed Web of Science ®Google Scholar
• GrossmanHJGrossmanVLBhatalPSIntrahepatic vascular resistance in cirrhosisBoschJGroszmannRJPortal Hypertension: Pathophysiology and TreatmentLondonBlackwell Scientific Publications1994116
   Google Scholar
• ZichaJDobešováZKunešJRelative deficiency of nitric oxide-dependent vasodilation in salt-hypertensive Dahl rats: the possible role of superoxide anionsJ Hypertens20011924725411212967
   PubMed Web of Science ®Google Scholar
• ZichaJDobešováZKunešJAntihypertensive mechanisms of chronic captopril or N-acetylcysteine treatment in L-NAME hypertensive ratsHypertens Res2006291021102717378375
   PubMed Web of Science ®Google Scholar
• PecháňováOZichaJPaulisLThe effect of N-acetylcysteine and melatonin in adult spontaneously hypertensive rats with established hypertensionEur J Pharmacol200756112913617321519
   PubMed Web of Science ®Google Scholar
• LinzWWiemerGSchaperJAngiotensin converting enzyme inhibitors, left ventricular hypertrophy and fibrosisMol Cell Biochem19951471–289977494560
   PubMed Web of Science ®Google Scholar
• NakamuraYYamamotoYMuraokaIAutonomic control of heart rate during physical exercise and fractal dimension of heart rate variabilityJ Appl Physiol19937428758818458809
   PubMed Web of Science ®Google Scholar
• ŠimkoFLeft ventricular hypertrophy regression as a process with variable biological implicationsCan J Cardiol19961255075138640598
   PubMed Web of Science ®Google Scholar
• TakemotoMEgashiraKUsuiMImportant role of tissue angiotensin-converting enzyme activity in the pathogenesis of coronary vascular and myocardial structural changes induced by long-term blockade of nitric oxide synthesis in ratsJ Clin Invest1997992782879005996
   PubMed Web of Science ®Google Scholar
• LinzWWiemerGSchölkensBAACE-inhibition induces NO-formation in cultured bovine endothelial cells and protects isolated ischemic rat heartsJ Mol Cell Cardiol19922489099191331474
   PubMed Web of Science ®Google Scholar
• RitchieRHMarshJDLancasterWDDiglioCASchiebingerRJBradykinin blocks angiotensin II-induced hypertrophy in the presence of endothelial cellsHypertension199831139449449388
   PubMed Web of Science ®Google Scholar
• KobayashiNHaraKWatanabeSHigashiTMatsuokaHEffect of imidapril on myocardial remodeling in L-NAME–induced hypertensive rats is associated with gene expression of NOS and ACE mRNAAm J Hypertens20001319920710701821
   PubMed Web of Science ®Google Scholar
• KhattabMMMostafaAAl-ShabanahOEffects of captopril on cardiac and renal damage, and metabolic alterations in the nitric oxide-deficient hypertensive ratKidney Blood Press Res200528424325016220007
   PubMed Web of Science ®Google Scholar
• UsuiMEgashiraKKitamotoSPathogenic role of oxidative stress in vascular angiotensin-converting enzyme activation in long-term blockade of nitric oxide synthesis in ratsHypertension19993454655110523324
   PubMed Web of Science ®Google Scholar
• KopkanLMajidDSEnhanced superoxide activity modulates renal function in NO-deficient hypertensive ratsHypertension200647356857216401762
   PubMed Web of Science ®Google Scholar
• OzgunerFOktemFAyataAKoyuAYilmazHRA novel antioxidant agent caffeic acid phenethyl ester (CAPE) prevents long term mobile phone exposure-induced renal impairment in rat: prognostic value of malondialdehyde, N-acetyl-β-D-glucosaminidase and nitric oxide determinationMol Cell Biochem2005277738016132717
   PubMed Web of Science ®Google Scholar
• OktemFKirbasAArmaganALisinopril attenuates renal oxidative injury in L-NAME-induced hypertensive ratsMol Cell Biochem20113521–224725321479940
   PubMed Web of Science ®Google Scholar
• NabhaLGarbernJCBullerCLCharpieJRVascular oxidative stress precedes high blood pressure in spontaneously hypertensive ratsClin Exp Hypertens2005271718215773231
   PubMed Web of Science ®Google Scholar
• JeserichMIhlingCAllgaierHPBergPAHeilmannCAcute liver failure due to enalaprilHerz200025768969311141678
   PubMed Web of Science ®Google Scholar
• Gonzalez de la PuenteMACalderonEEspinosaRRincónMVarelaJMFatal hepatotoxicity associated with enalaprilAnn Pharmacother200135149211724106
   PubMed Web of Science ®Google Scholar
• GokcimenAKocakAKilbasSEffect of lisinopril on rat liver tissues in L-NAME induced hypertension modelMol Cell Biochem200729615916416988888
   PubMed Web of Science ®Google Scholar
• HagleyMTHuliszDTBurnsCMHepatotoxicity associated with angiotensin-converting enzyme inhibitorsAnn Pharmacother19932722282318292107
   PubMed Web of Science ®Google Scholar